Published • loading... • Updated
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
Summary by Charleston Gazette-Mail
22 Articles
22 Articles
keenesentinel.com+21 Reposted by 21 other sources
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
First Phase 1 data for sofetabart mipitecan, Lilly's investigational FRα-targeting ADC, in platinum-sensitive ovarian cancer to be featured in a rapid oral presentation
Coverage Details
Total News Sources22
Leaning Left2Leaning Right3Center13Last UpdatedBias Distribution72% Center
Bias Distribution
- 72% of the sources are Center
72% Center
11%
C 72%
R 17%
Factuality
To view factuality data please Upgrade to Premium
